What Venture's Top Voices Expect Next in AI

Defining AI Native Companies

• 💡 Sarah Tavel from Benchmark emphasizes that true AI native companies deeply immerse their CEOs in AI, unlike those with isolated or superficial adoption.
• 🚀 A key symptom of genuine AI adoption is a shorter-term product roadmap, as AI-native founders understand the rapid changes and current capabilities of the technology.
• 🧠 AI requires unlearning self-reliance, moving from the "let me Google that for you" mindset to delegating tasks and using AI as a thought partner, a behavior younger generations may adopt more easily.

Investing in AI Founders

• 🎯 Mike Dauber and Sunil Dhaliwal of Amplify Partners highlight the intense competition for technical founders in the AI space, with significant capital chasing talent.
• 🔑 Their strategy involves getting to founders early and demonstrating value before they start companies, which puts them in a strong position for deals.
• 💰 The challenge for VCs lies in making investments at a price that makes sense, as abundant capital can lead to inflated valuations that don't align with future exit potential.

Market Trends and VC Timing

• 📈 Micah Rosenbloom of Founder Collective notes that venture capitalists are often seven years too late to major trends, citing examples like OpenAI being founded when VR/AR was the hot topic.
• 🌐 AI's impact is broad and pervasive, affecting almost every industry, unlike more niche innovations like crypto.
• ⚠️ There's a current "weird bull market" in venture, with high stock market valuations concentrated in a few companies, creating a challenging environment for early-stage investors due to talent siphoning and FOMO investing.

AI's Role in Biotech

• 🔬 Zach Weinberg from Curie Bio explains that AI's impact in biotech is limited by the physical nature of experiments, slow feedback loops, and the scarcity of high-quality training data.
• 🧪 While AI can improve specific steps, like protein shape prediction (AlphaFold), the idea of AI solely discovering drugs is currently a "fantasy" due to the complexity of biology and limited understanding of how cells work.
• 🏥 AI is expected to have a materially bigger impact in healthcare services, particularly in administrative tasks, rather than in fundamental drug discovery.

Evolving AI Opportunities

• ✨ Sarah Tavel identifies the opportunity to deliver "100x better experience cheaper" to consumers using AI, enabling previously expensive or time-consuming tasks like video creation or coaching.
• 🛠️ In the early stages of a new tech era, technical genius founders are crucial for building foundational infrastructure, but as the ecosystem matures, product genius becomes more prominent.
• 🔄 The AI landscape is changing rapidly, requiring "strong opinions loosely held" and constant adaptation of assumptions and frameworks, with value accruing to those who own the user or developer.

Future Market Outlook

• ⏸️ Nick Chirls anticipates a market pause or cool-down period in AI venture funding to assess the durability of companies and identify which ones are truly sustainable businesses.
• 📊 He suggests that major IPOs, such as Anthropic or OpenAI, could signal a market top for AI venture funding.
• 🌍 The broader implications of AI on workforces and product rollouts are still being understood, with a desire for an optimistic future but an acknowledgment of potential challenges.